Showing results (1351-1360 of 1,614) with videos related to
Sort By:
Pageof 162
RSC Medicinal Chemistry|July 11, 2022
Identification of ligand linkage vectors for the development of p300/CBP degradersDuncan K Brownsey, Ben C Rowley, Evgueni Gorobets, et al.RSC Medicinal Chemistry|July 11, 2022
Encoding BRAF inhibitor functions in protein degradersDaniel S J Miller, Sabine A Voell, Izidor Sosič, et al.RSC Medicinal Chemistry|July 11, 2022
Copper chelating cyclic peptidomimetic inhibits Aβ fibrillogenesisSujan Kalita, Sourav Kalita, Altaf Hussain Kawa, et al.RSC Medicinal Chemistry|May 27, 2021
Peptide directed phthalocyanine-gold nanoparticles for selective photodynamic therapy of EGFR overexpressing cancersZoë Rachael Goddard, Andrew Michael Beekman, Marco M D Cominetti, et al.RSC Medicinal Chemistry|May 27, 2021
Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood-brain barrier permeabilityChiara Borsari, Erhan Keles, Andrea Treyer, et al.RSC Medicinal Chemistry|January 22, 2021
Structure-based design and analysis of SuFEx chemical probesLyn H Jones, Jeffery W KellyRSC Medicinal Chemistry|January 22, 2021
Synthesis and evaluation of novel 2,4-disubstituted arylthiazoles against T. bruceiMarkos-Orestis Georgiadis, Violeta Kourbeli, Ioannis P Papanastasiou, et al.RSC Medicinal Chemistry|January 22, 2021
Potent trifluoromethoxy, trifluoromethylsulfonyl, trifluoromethylthio and pentafluorosulfanyl containing (1,3,4-oxadiazol-2-yl)benzamides against drug-resistant Gram-positive bacteriaGeorge A Naclerio, Nader S Abutaleb, Kenneth I Onyedibe, et al.RSC Medicinal Chemistry|January 22, 2021
Antiproliferative activities of tricyclic amides derived from β-caryophyllene via the Ritter reaction against MDA-MB-231 breast cancer cellsXiXi Xu, Ariane Roseblade, Tristan Rawling, et al.RSC Medicinal Chemistry|January 22, 2021
Recent progress in the discovery of ghrelin O-acyltransferase (GOAT) inhibitorsMalliga R Iyer, Casey M Wood, George KunosPageof 162